RPS26P35

Across TCGA pan-cancer cohorts, RPS26P35 RNA is linked to patient survival in 22 of 34 cancer types, making it the most broadly survival-associated RPS26P35 data layer.

The strongest signal is observed in cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC), where higher RPS26P35 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated RPS26P35 expression acts as an unfavorable survival marker, although some lineages such as CESC and THCA show a favorable association.

CESC, THCA, and UVM are the cancer types where RPS26P35 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CESC	DFS	Median	III,IV	0.833	0.565	.002	100	view →
THCA	OS	Median	II,III,IV	1.000	0.918	.003	47	view →
UVM	OS	Tertile	III,IV	0.255	0.762	.007	38	view →
ACC	DFS	Median	II,III,IV	0.294	0.706	.002	38	view →
UCEC	DFS	Median	All	0.587	0.672	.008	36	view →
BRCA	OS	Tertile	III,IV	0.754	0.387	.001	34	view →
MESO	OS	Tertile	IV	0.189	0.657	.002	31	view →
LUAD	OS	Tertile	III,IV	0.494	0.832	.001	31	view →
READ	OS	Median	IV	0.462	0.868	.002	23	view →
BLCA	OS	Median	All	0.523	0.253	.011	18	view →
SARC	OS	Median	All	0.727	0.873	.005	10	view →
LIHC	DFS	Quartile	All	0.361	0.573	.013	10	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 22 lineages.

RPS26P35–CESC (DFS)

Open the CESC breakdown →